Multiple Myeloma Clinical Trial

Clinical Trial Finder Multiple Myeloma Trials

A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat

See Locations Near You

Summary

This study aims to describe current treatment patterns in the real-world setting among patients with multiple myeloma who are initiating treatment with (or changing treatment to) panobinostat and explore the associations with baseline patient characteristics, healthcare resource utilization, and clinical outcomes.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Willing and able to provide written informed consent
At least 18 years of age
Clinical diagnosis of multiple myeloma that meets published diagnostic criteria
Initiating panobinostat within 60 days of enrollment
ECOG performance status 0-1
Availability of documentation from the patient's medical records regarding previous myeloma treatment, response, and duration of response
Willing and able to complete the PRO questionnaire

Exclusion Criteria:

Diagnosed with any B-cell malignancy other than myeloma
Estimated life expectancy <6 months
Currently enrolled in any interventional clinical trial at study entry (note: patients who enroll in an interventional clinical trial after enrollment may remain in the registry)

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

248

Study ID:

NCT04150289

Recruitment Status:

Completed

Sponsor:

zr Pharma & GmbH

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

American Health Network Indiana
Indianapolis Indiana, 46260, United States
Southern Nevada Cancer Research Foundation and Optum Cancer Care
Las Vegas Nevada, 89106, United States
Oncology Specialists of Charlotte
Charlotte North Carolina, 28204, United States
Southern Oncology Specialists
Huntersville North Carolina, 28078, United States
Gettysburg Cancer Center
Gettysburg Pennsylvania, 17325, United States
Coastal Cancer Center
Myrtle Beach South Carolina, 29572, United States
Carolina Blood and Cancer Care Associates
Rock Hill South Carolina, 29732, United States
Load More

How clear is this clinincal trial information?

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

248

Study ID:

NCT04150289

Recruitment Status:

Completed

Sponsor:


zr Pharma & GmbH

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider